nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ALB—Liothyronine—hypothyroidism	0.132	0.221	CbGbCtD
Captopril—ALB—Levothyroxine—hypothyroidism	0.132	0.221	CbGbCtD
Captopril—ALB—Liotrix—hypothyroidism	0.129	0.215	CbGbCtD
Captopril—ABCB1—Liothyronine—hypothyroidism	0.069	0.115	CbGbCtD
Captopril—ABCB1—Levothyroxine—hypothyroidism	0.069	0.115	CbGbCtD
Captopril—ABCB1—Liotrix—hypothyroidism	0.0673	0.113	CbGbCtD
Captopril—REN—urine—hypothyroidism	0.0111	0.0712	CbGeAlD
Captopril—F2—urine—hypothyroidism	0.00771	0.0496	CbGeAlD
Captopril—REN—nerve—hypothyroidism	0.00763	0.0491	CbGeAlD
Captopril—Serum sickness—Levothyroxine—hypothyroidism	0.00732	0.042	CcSEcCtD
Captopril—Serum sickness—Dextrothyroxine—hypothyroidism	0.00732	0.042	CcSEcCtD
Captopril—Gastric irritation—Liotrix—hypothyroidism	0.00651	0.0374	CcSEcCtD
Captopril—Serum sickness—Liotrix—hypothyroidism	0.00538	0.0309	CcSEcCtD
Captopril—Epigastric discomfort—Liotrix—hypothyroidism	0.0048	0.0276	CcSEcCtD
Captopril—ACE—urine—hypothyroidism	0.00471	0.0303	CbGeAlD
Captopril—Acidosis—Liotrix—hypothyroidism	0.00456	0.0262	CcSEcCtD
Captopril—Angina pectoris—Liothyronine—hypothyroidism	0.00427	0.0245	CcSEcCtD
Captopril—LTA4H—adrenal cortex—hypothyroidism	0.0038	0.0244	CbGeAlD
Captopril—LTA4H—heart—hypothyroidism	0.00367	0.0236	CbGeAlD
Captopril—LTA4H—cardiovascular system—hypothyroidism	0.00346	0.0223	CbGeAlD
Captopril—ACE—nerve—hypothyroidism	0.00325	0.0209	CbGeAlD
Captopril—Necrosis—Liotrix—hypothyroidism	0.00322	0.0185	CcSEcCtD
Captopril—MMP2—EPH-ephrin mediated repulsion of cells—CLTC—hypothyroidism	0.00322	0.0442	CbGpPWpGaD
Captopril—REN—Peptide hormone metabolism—TSHB—hypothyroidism	0.00316	0.0434	CbGpPWpGaD
Captopril—LTA4H—gonad—hypothyroidism	0.00314	0.0202	CbGeAlD
Captopril—LTA4H—pituitary gland—hypothyroidism	0.00307	0.0197	CbGeAlD
Captopril—MMP9—Endochondral Ossification—THRA—hypothyroidism	0.00297	0.0408	CbGpPWpGaD
Captopril—REN—adrenal cortex—hypothyroidism	0.00293	0.0189	CbGeAlD
Captopril—REN—heart—hypothyroidism	0.00283	0.0182	CbGeAlD
Captopril—LTA4H—adrenal gland—hypothyroidism	0.00274	0.0176	CbGeAlD
Captopril—Oliguria—Liotrix—hypothyroidism	0.00274	0.0157	CcSEcCtD
Captopril—LTA4H—blood—hypothyroidism	0.00274	0.0176	CbGeAlD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—hypothyroidism	0.00274	0.0376	CbGpPWpGaD
Captopril—MMP2—adrenal cortex—hypothyroidism	0.00269	0.0173	CbGeAlD
Captopril—REN—cardiovascular system—hypothyroidism	0.00267	0.0172	CbGeAlD
Captopril—Ulcer—Liotrix—hypothyroidism	0.00267	0.0153	CcSEcCtD
Captopril—LTA4H—thyroid gland—hypothyroidism	0.00264	0.017	CbGeAlD
Captopril—MMP2—heart—hypothyroidism	0.0026	0.0168	CbGeAlD
Captopril—LTA4H—female gonad—hypothyroidism	0.00255	0.0164	CbGeAlD
Captopril—MMP2—cardiovascular system—hypothyroidism	0.00246	0.0158	CbGeAlD
Captopril—Tachycardia—Liothyronine—hypothyroidism	0.00243	0.014	CcSEcCtD
Captopril—Cardiac arrest—Levothyroxine—hypothyroidism	0.00237	0.0136	CcSEcCtD
Captopril—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00237	0.0136	CcSEcCtD
Captopril—REN—pituitary gland—hypothyroidism	0.00237	0.0152	CbGeAlD
Captopril—Hypotension—Liothyronine—hypothyroidism	0.00233	0.0134	CcSEcCtD
Captopril—CYP2D6—urine—hypothyroidism	0.00231	0.0148	CbGeAlD
Captopril—LTA4H—testis—hypothyroidism	0.00227	0.0146	CbGeAlD
Captopril—MMP9—heart—hypothyroidism	0.00226	0.0146	CbGeAlD
Captopril—MMP2—gonad—hypothyroidism	0.00223	0.0144	CbGeAlD
Captopril—Muscular weakness—Levothyroxine—hypothyroidism	0.0022	0.0126	CcSEcCtD
Captopril—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0022	0.0126	CcSEcCtD
Captopril—MMP2—pituitary gland—hypothyroidism	0.00218	0.014	CbGeAlD
Captopril—MMP2—Osteopontin-mediated events—VAV3—hypothyroidism	0.00215	0.0296	CbGpPWpGaD
Captopril—LTA4H—liver—hypothyroidism	0.00214	0.0138	CbGeAlD
Captopril—MMP9—cardiovascular system—hypothyroidism	0.00214	0.0138	CbGeAlD
Captopril—REN—adrenal gland—hypothyroidism	0.00211	0.0136	CbGeAlD
Captopril—REN—blood—hypothyroidism	0.00211	0.0136	CbGeAlD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—CLTC—hypothyroidism	0.00211	0.029	CbGpPWpGaD
Captopril—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0021	0.012	CcSEcCtD
Captopril—Angina pectoris—Levothyroxine—hypothyroidism	0.0021	0.012	CcSEcCtD
Captopril—LTA4H—cerebellum—hypothyroidism	0.00209	0.0135	CbGeAlD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00209	0.0287	CbGpPWpGaD
Captopril—Renal failure acute—Liotrix—hypothyroidism	0.00198	0.0114	CcSEcCtD
Captopril—F2—heart—hypothyroidism	0.00198	0.0127	CbGeAlD
Captopril—REN—female gonad—hypothyroidism	0.00197	0.0127	CbGeAlD
Captopril—Body temperature increased—Liothyronine—hypothyroidism	0.00197	0.0113	CcSEcCtD
Captopril—Weight decreased—Levothyroxine—hypothyroidism	0.00195	0.0112	CcSEcCtD
Captopril—Weight decreased—Dextrothyroxine—hypothyroidism	0.00195	0.0112	CcSEcCtD
Captopril—MMP2—adrenal gland—hypothyroidism	0.00194	0.0125	CbGeAlD
Captopril—MMP2—blood—hypothyroidism	0.00194	0.0125	CbGeAlD
Captopril—MMP2—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00188	0.0258	CbGpPWpGaD
Captopril—MMP2—thyroid gland—hypothyroidism	0.00188	0.0121	CbGeAlD
Captopril—Cerebrovascular accident—Liotrix—hypothyroidism	0.00187	0.0107	CcSEcCtD
Captopril—F2—cardiovascular system—hypothyroidism	0.00186	0.012	CbGeAlD
Captopril—MMP2—female gonad—hypothyroidism	0.00181	0.0117	CbGeAlD
Captopril—MMP2—Regulation of IGF Activity by IGFBP—IGF1—hypothyroidism	0.00181	0.0249	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—BGLAP—hypothyroidism	0.0018	0.0247	CbGpPWpGaD
Captopril—Cardiac arrest—Liotrix—hypothyroidism	0.00174	0.01	CcSEcCtD
Captopril—MMP9—adrenal gland—hypothyroidism	0.00169	0.0109	CbGeAlD
Captopril—MMP9—blood—hypothyroidism	0.00169	0.0109	CbGeAlD
Captopril—REN—liver—hypothyroidism	0.00165	0.0106	CbGeAlD
Captopril—Muscular weakness—Liotrix—hypothyroidism	0.00162	0.00928	CcSEcCtD
Captopril—REN—cerebellum—hypothyroidism	0.00161	0.0104	CbGeAlD
Captopril—MMP2—testis—hypothyroidism	0.00161	0.0103	CbGeAlD
Captopril—Flushing—Dextrothyroxine—hypothyroidism	0.0016	0.00919	CcSEcCtD
Captopril—Flushing—Levothyroxine—hypothyroidism	0.0016	0.00919	CcSEcCtD
Captopril—MMP9—female gonad—hypothyroidism	0.00158	0.0101	CbGeAlD
Captopril—Bronchospasm—Liotrix—hypothyroidism	0.00156	0.00895	CcSEcCtD
Captopril—Angina pectoris—Liotrix—hypothyroidism	0.00154	0.00886	CcSEcCtD
Captopril—Alopecia—Dextrothyroxine—hypothyroidism	0.00152	0.00875	CcSEcCtD
Captopril—Alopecia—Levothyroxine—hypothyroidism	0.00152	0.00875	CcSEcCtD
Captopril—MMP2—liver—hypothyroidism	0.00152	0.00978	CbGeAlD
Captopril—MMP2—EPH-ephrin mediated repulsion of cells—VAV3—hypothyroidism	0.00152	0.0208	CbGpPWpGaD
Captopril—F2—adrenal gland—hypothyroidism	0.00147	0.00949	CbGeAlD
Captopril—F2—blood—hypothyroidism	0.00147	0.00949	CbGeAlD
Captopril—Tension—Levothyroxine—hypothyroidism	0.00147	0.00846	CcSEcCtD
Captopril—Tension—Dextrothyroxine—hypothyroidism	0.00147	0.00846	CcSEcCtD
Captopril—Nervousness—Dextrothyroxine—hypothyroidism	0.00146	0.00837	CcSEcCtD
Captopril—Nervousness—Levothyroxine—hypothyroidism	0.00146	0.00837	CcSEcCtD
Captopril—Weight decreased—Liotrix—hypothyroidism	0.00143	0.00823	CcSEcCtD
Captopril—MMP9—Osteopontin-mediated events—VAV3—hypothyroidism	0.00141	0.0194	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00141	0.0194	CbGpPWpGaD
Captopril—MMP9—testis—hypothyroidism	0.0014	0.009	CbGeAlD
Captopril—Renal failure—Liotrix—hypothyroidism	0.00139	0.00797	CcSEcCtD
Captopril—F2—Complement and Coagulation Cascades—CLTC—hypothyroidism	0.00138	0.019	CbGpPWpGaD
Captopril—F2—female gonad—hypothyroidism	0.00138	0.00885	CbGeAlD
Captopril—Angioedema—Levothyroxine—hypothyroidism	0.00137	0.00787	CcSEcCtD
Captopril—Angioedema—Dextrothyroxine—hypothyroidism	0.00137	0.00787	CcSEcCtD
Captopril—MMP9—FGF signaling pathway—BGLAP—hypothyroidism	0.00133	0.0182	CbGpPWpGaD
Captopril—Palpitations—Dextrothyroxine—hypothyroidism	0.00133	0.00762	CcSEcCtD
Captopril—Palpitations—Levothyroxine—hypothyroidism	0.00133	0.00762	CcSEcCtD
Captopril—MMP9—liver—hypothyroidism	0.00132	0.0085	CbGeAlD
Captopril—Arthralgia—Levothyroxine—hypothyroidism	0.00128	0.00734	CcSEcCtD
Captopril—Arthralgia—Dextrothyroxine—hypothyroidism	0.00128	0.00734	CcSEcCtD
Captopril—ALB—heart—hypothyroidism	0.00126	0.00812	CbGeAlD
Captopril—REN—Peptide hormone metabolism—POMC—hypothyroidism	0.00124	0.017	CbGpPWpGaD
Captopril—Confusional state—Dextrothyroxine—hypothyroidism	0.00123	0.00709	CcSEcCtD
Captopril—Confusional state—Levothyroxine—hypothyroidism	0.00123	0.00709	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00123	0.0169	CbGpPWpGaD
Captopril—ACE—heart—hypothyroidism	0.00121	0.00777	CbGeAlD
Captopril—Shock—Dextrothyroxine—hypothyroidism	0.0012	0.00692	CcSEcCtD
Captopril—Shock—Levothyroxine—hypothyroidism	0.0012	0.00692	CcSEcCtD
Captopril—Tachycardia—Levothyroxine—hypothyroidism	0.0012	0.00686	CcSEcCtD
Captopril—Tachycardia—Dextrothyroxine—hypothyroidism	0.0012	0.00686	CcSEcCtD
Captopril—REN—Peptide hormone metabolism—IGF1—hypothyroidism	0.00119	0.0164	CbGpPWpGaD
Captopril—Flushing—Liotrix—hypothyroidism	0.00118	0.00676	CcSEcCtD
Captopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.00116	0.0159	CbGpPWpGaD
Captopril—F2—liver—hypothyroidism	0.00115	0.00742	CbGeAlD
Captopril—ACE—cardiovascular system—hypothyroidism	0.00114	0.00733	CbGeAlD
Captopril—Alopecia—Liotrix—hypothyroidism	0.00112	0.00643	CcSEcCtD
Captopril—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00112	0.00641	CcSEcCtD
Captopril—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00112	0.00641	CcSEcCtD
Captopril—Insomnia—Levothyroxine—hypothyroidism	0.00111	0.00636	CcSEcCtD
Captopril—Insomnia—Dextrothyroxine—hypothyroidism	0.00111	0.00636	CcSEcCtD
Captopril—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00109	0.00627	CcSEcCtD
Captopril—Dyspnoea—Levothyroxine—hypothyroidism	0.00109	0.00627	CcSEcCtD
Captopril—Tension—Liotrix—hypothyroidism	0.00108	0.00622	CcSEcCtD
Captopril—Dysgeusia—Liotrix—hypothyroidism	0.00108	0.00621	CcSEcCtD
Captopril—Nervousness—Liotrix—hypothyroidism	0.00107	0.00616	CcSEcCtD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00106	0.0146	CbGpPWpGaD
Captopril—Fatigue—Levothyroxine—hypothyroidism	0.00106	0.00606	CcSEcCtD
Captopril—Fatigue—Dextrothyroxine—hypothyroidism	0.00106	0.00606	CcSEcCtD
Captopril—Vision blurred—Liotrix—hypothyroidism	0.00104	0.00597	CcSEcCtD
Captopril—ACE—gonad—hypothyroidism	0.00103	0.00665	CbGeAlD
Captopril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00102	0.014	CbGpPWpGaD
Captopril—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00101	0.0058	CcSEcCtD
Captopril—Feeling abnormal—Levothyroxine—hypothyroidism	0.00101	0.0058	CcSEcCtD
Captopril—ACE—pituitary gland—hypothyroidism	0.00101	0.00649	CbGeAlD
Captopril—Angioedema—Liotrix—hypothyroidism	0.00101	0.00579	CcSEcCtD
Captopril—LTA4H—Metabolism—IYD—hypothyroidism	0.001	0.0138	CbGpPWpGaD
Captopril—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.001	0.00575	CcSEcCtD
Captopril—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.001	0.00575	CcSEcCtD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—VAV3—hypothyroidism	0.000994	0.0137	CbGpPWpGaD
Captopril—Syncope—Liotrix—hypothyroidism	0.00099	0.00568	CcSEcCtD
Captopril—SLC15A1—liver—hypothyroidism	0.000983	0.00632	CbGeAlD
Captopril—Palpitations—Liotrix—hypothyroidism	0.000975	0.0056	CcSEcCtD
Captopril—Loss of consciousness—Liotrix—hypothyroidism	0.00097	0.00557	CcSEcCtD
Captopril—Abdominal pain—Levothyroxine—hypothyroidism	0.000968	0.00556	CcSEcCtD
Captopril—Body temperature increased—Levothyroxine—hypothyroidism	0.000968	0.00556	CcSEcCtD
Captopril—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000968	0.00556	CcSEcCtD
Captopril—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000968	0.00556	CcSEcCtD
Captopril—ALB—Transport of organic anions—AVP—hypothyroidism	0.000954	0.0131	CbGpPWpGaD
Captopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.00095	0.0131	CbGpPWpGaD
Captopril—ALB—adrenal gland—hypothyroidism	0.000941	0.00606	CbGeAlD
Captopril—Chest pain—Liotrix—hypothyroidism	0.00094	0.0054	CcSEcCtD
Captopril—Arthralgia—Liotrix—hypothyroidism	0.00094	0.0054	CcSEcCtD
Captopril—F2—Regulation of IGF Activity by IGFBP—IGF1—hypothyroidism	0.000916	0.0126	CbGpPWpGaD
Captopril—Confusional state—Liotrix—hypothyroidism	0.000908	0.00522	CcSEcCtD
Captopril—ACE—adrenal gland—hypothyroidism	0.000901	0.0058	CbGeAlD
Captopril—ACE—blood—hypothyroidism	0.000901	0.0058	CbGeAlD
Captopril—Anaphylactic shock—Liotrix—hypothyroidism	0.000901	0.00517	CcSEcCtD
Captopril—Shock—Liotrix—hypothyroidism	0.000886	0.00509	CcSEcCtD
Captopril—MMP2—EPH-Ephrin signaling—VAV3—hypothyroidism	0.000885	0.0122	CbGpPWpGaD
Captopril—Tachycardia—Liotrix—hypothyroidism	0.000879	0.00505	CcSEcCtD
Captopril—Asthenia—Dextrothyroxine—hypothyroidism	0.000879	0.00505	CcSEcCtD
Captopril—Asthenia—Levothyroxine—hypothyroidism	0.000879	0.00505	CcSEcCtD
Captopril—ACE—thyroid gland—hypothyroidism	0.000869	0.0056	CbGeAlD
Captopril—Pruritus—Dextrothyroxine—hypothyroidism	0.000866	0.00498	CcSEcCtD
Captopril—Pruritus—Levothyroxine—hypothyroidism	0.000866	0.00498	CcSEcCtD
Captopril—Anorexia—Liotrix—hypothyroidism	0.000859	0.00493	CcSEcCtD
Captopril—LTA4H—Metabolism—ATP5O—hypothyroidism	0.000852	0.0117	CbGpPWpGaD
Captopril—Hypotension—Liotrix—hypothyroidism	0.000842	0.00483	CcSEcCtD
Captopril—ACE—female gonad—hypothyroidism	0.00084	0.00541	CbGeAlD
Captopril—Diarrhoea—Levothyroxine—hypothyroidism	0.000838	0.00481	CcSEcCtD
Captopril—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000838	0.00481	CcSEcCtD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000828	0.0114	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000821	0.00471	CcSEcCtD
Captopril—Insomnia—Liotrix—hypothyroidism	0.000815	0.00468	CcSEcCtD
Captopril—Paraesthesia—Liotrix—hypothyroidism	0.000809	0.00465	CcSEcCtD
Captopril—Dyspnoea—Liotrix—hypothyroidism	0.000803	0.00461	CcSEcCtD
Captopril—LTA4H—Metabolism—TPO—hypothyroidism	0.000801	0.011	CbGpPWpGaD
Captopril—Decreased appetite—Liotrix—hypothyroidism	0.000783	0.0045	CcSEcCtD
Captopril—Vomiting—Dextrothyroxine—hypothyroidism	0.000779	0.00447	CcSEcCtD
Captopril—Vomiting—Levothyroxine—hypothyroidism	0.000779	0.00447	CcSEcCtD
Captopril—ALB—testis—hypothyroidism	0.000778	0.00501	CbGeAlD
Captopril—Fatigue—Liotrix—hypothyroidism	0.000777	0.00446	CcSEcCtD
Captopril—Rash—Dextrothyroxine—hypothyroidism	0.000772	0.00443	CcSEcCtD
Captopril—Rash—Levothyroxine—hypothyroidism	0.000772	0.00443	CcSEcCtD
Captopril—Dermatitis—Dextrothyroxine—hypothyroidism	0.000771	0.00443	CcSEcCtD
Captopril—Dermatitis—Levothyroxine—hypothyroidism	0.000771	0.00443	CcSEcCtD
Captopril—Constipation—Liotrix—hypothyroidism	0.00077	0.00442	CcSEcCtD
Captopril—Headache—Dextrothyroxine—hypothyroidism	0.000767	0.00441	CcSEcCtD
Captopril—Headache—Levothyroxine—hypothyroidism	0.000767	0.00441	CcSEcCtD
Captopril—ACE—testis—hypothyroidism	0.000745	0.00479	CbGeAlD
Captopril—Feeling abnormal—Liotrix—hypothyroidism	0.000742	0.00426	CcSEcCtD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000742	0.0102	CbGpPWpGaD
Captopril—Gastrointestinal pain—Liotrix—hypothyroidism	0.000737	0.00423	CcSEcCtD
Captopril—ALB—liver—hypothyroidism	0.000736	0.00474	CbGeAlD
Captopril—Nausea—Dextrothyroxine—hypothyroidism	0.000727	0.00418	CcSEcCtD
Captopril—Nausea—Levothyroxine—hypothyroidism	0.000727	0.00418	CcSEcCtD
Captopril—Body temperature increased—Liotrix—hypothyroidism	0.000712	0.00409	CcSEcCtD
Captopril—Abdominal pain—Liotrix—hypothyroidism	0.000712	0.00409	CcSEcCtD
Captopril—ACE—liver—hypothyroidism	0.000704	0.00453	CbGeAlD
Captopril—MMP2—Axon guidance—CLTC—hypothyroidism	0.000698	0.0096	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000695	0.00955	CbGpPWpGaD
Captopril—Asthenia—Liotrix—hypothyroidism	0.000646	0.00371	CcSEcCtD
Captopril—Pruritus—Liotrix—hypothyroidism	0.000637	0.00366	CcSEcCtD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000625	0.0086	CbGpPWpGaD
Captopril—Diarrhoea—Liotrix—hypothyroidism	0.000616	0.00354	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000612	0.00841	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—TSHB—hypothyroidism	0.000596	0.0082	CbGpPWpGaD
Captopril—Dizziness—Liotrix—hypothyroidism	0.000596	0.00342	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—VAV3—hypothyroidism	0.000581	0.00798	CbGpPWpGaD
Captopril—Vomiting—Liotrix—hypothyroidism	0.000573	0.00329	CcSEcCtD
Captopril—Rash—Liotrix—hypothyroidism	0.000568	0.00326	CcSEcCtD
Captopril—Dermatitis—Liotrix—hypothyroidism	0.000567	0.00326	CcSEcCtD
Captopril—Headache—Liotrix—hypothyroidism	0.000564	0.00324	CcSEcCtD
Captopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.000559	0.00769	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—POMC—hypothyroidism	0.000552	0.0076	CbGpPWpGaD
Captopril—Nausea—Liotrix—hypothyroidism	0.000535	0.00307	CcSEcCtD
Captopril—ACE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000531	0.00731	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000518	0.00713	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CLTC—hypothyroidism	0.000498	0.00685	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—IGF1—hypothyroidism	0.000486	0.00669	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—TRH—hypothyroidism	0.000474	0.00652	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000468	0.00644	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000464	0.00638	CbGpPWpGaD
Captopril—MMP9—Axon guidance—CLTC—hypothyroidism	0.000458	0.0063	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000452	0.00621	CbGpPWpGaD
Captopril—CYP2D6—blood—hypothyroidism	0.000441	0.00284	CbGeAlD
Captopril—ABCB1—adrenal cortex—hypothyroidism	0.000439	0.00283	CbGeAlD
Captopril—ABCB1—heart—hypothyroidism	0.000425	0.00273	CbGeAlD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000424	0.00583	CbGpPWpGaD
Captopril—CYP2D6—female gonad—hypothyroidism	0.000411	0.00265	CbGeAlD
Captopril—ABCB1—cardiovascular system—hypothyroidism	0.000401	0.00258	CbGeAlD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000385	0.00529	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TSHB—hypothyroidism	0.000371	0.0051	CbGpPWpGaD
Captopril—CYP2D6—testis—hypothyroidism	0.000365	0.00235	CbGeAlD
Captopril—ABCB1—gonad—hypothyroidism	0.000364	0.00234	CbGeAlD
Captopril—ABCB1—pituitary gland—hypothyroidism	0.000355	0.00228	CbGeAlD
Captopril—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000354	0.00486	CbGpPWpGaD
Captopril—CYP2D6—liver—hypothyroidism	0.000345	0.00222	CbGeAlD
Captopril—CYP2D6—cerebellum—hypothyroidism	0.000337	0.00217	CbGeAlD
Captopril—LTA4H—Metabolism—PIK3C2A—hypothyroidism	0.00033	0.00454	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VAV3—hypothyroidism	0.000329	0.00452	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CLTC—hypothyroidism	0.000327	0.00449	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000326	0.00448	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000318	0.00437	CbGpPWpGaD
Captopril—ABCB1—adrenal gland—hypothyroidism	0.000317	0.00204	CbGeAlD
Captopril—ABCB1—blood—hypothyroidism	0.000317	0.00204	CbGeAlD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000314	0.00432	CbGpPWpGaD
Captopril—ABCB1—thyroid gland—hypothyroidism	0.000306	0.00197	CbGeAlD
Captopril—MMP2—Metabolism of proteins—TSHB—hypothyroidism	0.000296	0.00407	CbGpPWpGaD
Captopril—ABCB1—female gonad—hypothyroidism	0.000296	0.0019	CbGeAlD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00028	0.00385	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00028	0.00385	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC5A5—hypothyroidism	0.000278	0.00382	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—TSHB—hypothyroidism	0.000266	0.00366	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000263	0.00362	CbGpPWpGaD
Captopril—ABCB1—testis—hypothyroidism	0.000262	0.00169	CbGeAlD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00025	0.00344	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—AVP—hypothyroidism	0.000249	0.00343	CbGpPWpGaD
Captopril—ABCB1—liver—hypothyroidism	0.000248	0.0016	CbGeAlD
Captopril—F2—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000246	0.00338	CbGpPWpGaD
Captopril—ABCB1—cerebellum—hypothyroidism	0.000242	0.00156	CbGeAlD
Captopril—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000241	0.00332	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TRH—hypothyroidism	0.000239	0.00329	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000236	0.00324	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VAV3—hypothyroidism	0.000235	0.00323	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—POMC—hypothyroidism	0.000233	0.00321	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000226	0.00311	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—IGF1—hypothyroidism	0.000225	0.00309	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000223	0.00306	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VAV3—hypothyroidism	0.000216	0.00297	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TSHB—hypothyroidism	0.000213	0.00293	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TSHR—hypothyroidism	0.000213	0.00293	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0002	0.00275	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000197	0.00271	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000195	0.00269	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000186	0.00255	CbGpPWpGaD
Captopril—F2—Hemostasis—SH2B3—hypothyroidism	0.00017	0.00234	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000165	0.00227	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000163	0.00225	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VAV3—hypothyroidism	0.000154	0.00212	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—TSHB—hypothyroidism	0.00015	0.00206	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000146	0.00201	CbGpPWpGaD
Captopril—LTA4H—Metabolism—POMC—hypothyroidism	0.000145	0.002	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000139	0.00192	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TRH—hypothyroidism	0.000135	0.00186	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000135	0.00185	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000127	0.00175	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—AVP—hypothyroidism	0.000126	0.00173	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—IGF1—hypothyroidism	0.000125	0.00171	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TRH—hypothyroidism	0.000123	0.00169	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000123	0.00169	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TSHB—hypothyroidism	0.00012	0.00166	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TSHR—hypothyroidism	0.00012	0.00166	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	0.000119	0.00163	CbGpPWpGaD
Captopril—F2—Hemostasis—VAV3—hypothyroidism	0.000117	0.0016	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—POMC—hypothyroidism	0.000116	0.00159	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—IGF1—hypothyroidism	0.000112	0.00153	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00011	0.00151	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TSHB—hypothyroidism	0.000109	0.0015	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TSHR—hypothyroidism	0.000109	0.0015	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000109	0.0015	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CLTC—hypothyroidism	0.000109	0.00149	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000107	0.00148	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—POMC—hypothyroidism	0.000104	0.00143	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000102	0.0014	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—IGF1—hypothyroidism	0.0001	0.00138	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.0001	0.00138	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.65e-05	0.00133	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.43e-05	0.0013	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TRH—hypothyroidism	9.39e-05	0.00129	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	8.98e-05	0.00123	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.9e-05	0.00122	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CLTC—hypothyroidism	8.39e-05	0.00115	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSHR—hypothyroidism	8.37e-05	0.00115	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSHB—hypothyroidism	8.37e-05	0.00115	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—POMC—hypothyroidism	8.35e-05	0.00115	CbGpPWpGaD
Captopril—ALB—Metabolism—IYD—hypothyroidism	8.29e-05	0.00114	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.59e-05	0.00104	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SH2B3—hypothyroidism	7.46e-05	0.00103	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—AVP—hypothyroidism	7.42e-05	0.00102	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—VAV3—hypothyroidism	7.37e-05	0.00101	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IYD—hypothyroidism	7.26e-05	0.000998	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TRH—hypothyroidism	7.25e-05	0.000997	CbGpPWpGaD
Captopril—F2—Hemostasis—IGF1—hypothyroidism	7.18e-05	0.000988	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AVP—hypothyroidism	7.1e-05	0.000976	CbGpPWpGaD
Captopril—ALB—Metabolism—ATP5O—hypothyroidism	7.05e-05	0.000969	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IYD—hypothyroidism	6.84e-05	0.000941	CbGpPWpGaD
Captopril—ALB—Hemostasis—SH2B3—hypothyroidism	6.74e-05	0.000927	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—VAV3—hypothyroidism	6.69e-05	0.00092	CbGpPWpGaD
Captopril—ALB—Metabolism—TPO—hypothyroidism	6.62e-05	0.000911	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSHB—hypothyroidism	6.46e-05	0.000889	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSHR—hypothyroidism	6.46e-05	0.000889	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AVP—hypothyroidism	6.45e-05	0.000887	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ATP5O—hypothyroidism	6.17e-05	0.000849	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.14e-05	0.000844	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—POMC—hypothyroidism	5.87e-05	0.000808	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ATP5O—hypothyroidism	5.82e-05	0.0008	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TPO—hypothyroidism	5.8e-05	0.000798	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—POMC—hypothyroidism	5.8e-05	0.000797	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SH2B3—hypothyroidism	5.76e-05	0.000792	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF1—hypothyroidism	5.65e-05	0.000777	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PRL—hypothyroidism	5.54e-05	0.000761	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	5.53e-05	0.00076	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TPO—hypothyroidism	5.47e-05	0.000752	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	5.44e-05	0.000749	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VAV3—hypothyroidism	5.12e-05	0.000704	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AVP—hypothyroidism	4.93e-05	0.000678	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.9e-05	0.000674	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—hypothyroidism	4.72e-05	0.000649	CbGpPWpGaD
Captopril—ALB—Hemostasis—VAV3—hypothyroidism	4.63e-05	0.000636	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.3e-05	0.000591	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—hypothyroidism	4.29e-05	0.000589	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRL—hypothyroidism	4.27e-05	0.000588	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VAV3—hypothyroidism	3.95e-05	0.000544	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	3.86e-05	0.000531	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AVP—hypothyroidism	3.81e-05	0.000524	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.38e-05	0.000465	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—hypothyroidism	3.28e-05	0.000451	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—hypothyroidism	3.15e-05	0.000434	CbGpPWpGaD
Captopril—ALB—Metabolism—TSHB—hypothyroidism	3.07e-05	0.000422	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—hypothyroidism	2.85e-05	0.000392	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3C2A—hypothyroidism	2.73e-05	0.000376	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.7e-05	0.000371	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TSHB—hypothyroidism	2.69e-05	0.00037	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TSHB—hypothyroidism	2.53e-05	0.000348	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—hypothyroidism	2.53e-05	0.000348	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—hypothyroidism	2.43e-05	0.000335	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.4e-05	0.000329	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—hypothyroidism	2.3e-05	0.000316	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	2.26e-05	0.00031	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.01e-05	0.000277	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.9e-05	0.000261	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—hypothyroidism	1.2e-05	0.000165	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—hypothyroidism	1.05e-05	0.000145	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—hypothyroidism	9.92e-06	0.000136	CbGpPWpGaD
